In concert with previous descriptions of CNS tumors (30), we have shown that the RTK/RAS (75%), PI3K (44%), TP53 (43%), cell cycle (21%), and NOTCH (21%) pathways were frequently altered in midline glioma. This evidence concerns the gene TP53 and central nervous system neoplasm.